Studies related to Blood Flow and Chromium

Chromium Effects On Glucose Tolerance And Insulin Sensitivity In Persons At Risk For Diabetes Mellitus

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 50
Sex Both Genders
Age Range 30-44, 45-64, 65+
Body Types Obese
Notes for this study:
Supplementation of chromium picolinate at 500mcg or 1,000mcg for six months in persons at risk for type II diabetes has failed to influence any biomarkers of glucose metabolism and was said to not confer any protection against the development of type II diabetes.